FRANKFURT AM MAIN: German company BioNTech, which developed the first coronavirus vaccine approved in the West, said Monday it expects to produce two billion doses in 2021, up from the 1.3 billion previously forecast.

“We now believe that we can potentially deliver approximately 2 billion doses in total by the end of 2021, which incorporates the updated six-dose label,” said the company, referring to an additional dose that could be extracted from each vial of the vaccine.